Single-Photon Emission Computed Tomographic Imaging of the Early Time Course of Therapy-Induced Cell Death Using Technetium 99m Tricarbonyl His-Annexin A5 in a Colorectal Cancer Xenograft Model
暂无分享,去创建一个
C. Reutelingsperger | P. Pauwels | C. Van de Wiele | M. Peeters | S. Staelens | C. Vangestel | K. Mertens | N. van Damme | G. Mees | N. Van Damme | Koen Mertens
[1] J. Philippé,et al. In vitro and in vivo evaluation of [99mTc]-labeled tricarbonyl His-annexin A5 as an imaging agent for the detection of phosphatidylserine-expressing cells. , 2010, Nuclear medicine and biology.
[2] A. Davidoff,et al. Bevacizumab-induced tumor vessel remodeling in rhabdomyosarcoma xenografts increases the effectiveness of adjuvant ionizing radiation. , 2010, Journal of pediatric surgery.
[3] T. Merchant,et al. Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation. , 2010, International journal of radiation oncology, biology, physics.
[4] A. Antonacopoulou,et al. Autophagy: novel action of panitumumab in colon cancer. , 2009, Anticancer research.
[5] F. J. Ramos,et al. Anti-epidermal growth factor receptor monoclonal antibodies in cancer treatment. , 2009, Cancer treatment reviews.
[6] Hua-Qin Wang,et al. Significance of survivin, caspase-3, and VEGF expression in thyroid carcinoma , 2009, Clinical and Experimental Medicine.
[7] F.A.M. Bordonaba,et al. Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer , 2009 .
[8] J. Medema,et al. Apoptosis and non-apoptotic deaths in cancer development and treatment response. , 2008, Cancer treatment reviews.
[9] F. Blankenberg,et al. In Vivo Detection of Apoptosis , 2008, Journal of Nuclear Medicine.
[10] H. Angell. A study into the potential role of Survivin localization in resistance to drug-induced apoptosis , 2008 .
[11] F. Hoebers,et al. 99mTc-HYNIC-rh-annexin-V scintigraphy: visual and quantitative evaluation of early treatment-induced apoptosis to predict treatment outcome , 2008, Nuclear medicine communications.
[12] Y. Doki,et al. LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers. , 2008, International journal of oncology.
[13] R. Epstein. VEGF signaling inhibitors: More pro-apoptotic than anti-angiogenic , 2007, Cancer and Metastasis Reviews.
[14] M. Verheij,et al. Prognostic significance of 99mTc Hynic-rh-annexin V scintigraphy during platinum-based chemotherapy in advanced lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] G. Slegers,et al. Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[16] F. Luo,et al. Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels , 2006, Molecular Cancer Therapeutics.
[17] Raymond Sawaya,et al. The role of autophagy in cancer development and response to therapy , 2005, Nature Reviews Cancer.
[18] Mi Ae Kim,et al. Two distinct modes of cell death induced by doxorubicin: apoptosis and cell death through mitotic catastrophe accompanied by senescence-like phenotype , 2005, Oncogene.
[19] P. Comfurius,et al. Surface exposure of phosphatidylserine in pathological cells , 2005, Cellular and Molecular Life Sciences CMLS.
[20] D. Vaux,et al. Apoptosis in the development and treatment of cancer. , 2004, Carcinogenesis.
[21] F. Blankenberg,et al. Time course of apoptotic tumor response after a single dose of chemotherapy: comparison with 99mTc-annexin V uptake and histologic findings in an experimental model. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[22] N. Mizushima. Methods for monitoring autophagy. , 2004, The international journal of biochemistry & cell biology.
[23] F. Hoebers,et al. In vivo imaging of apoptosis by 99mTc-Annexin V scintigraphy: visual analysis in relation to treatment response. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] Katharina D'Herde,et al. Correction for Phagocytosis of Necrotic Cells by Macrophages Is Phosphatidylserine Dependent and Does Not Induce Inflammatory Cytokine Production , 2003, Molecular biology of the cell.
[25] F. Blankenberg,et al. Multi-modality imaging identifies key times for annexin V imaging as an early predictor of therapeutic outcome. , 2004, Molecular imaging.
[26] G. Slegers,et al. Quantitative tumor apoptosis imaging using technetium-99m-HYNIC annexin V single photon emission computed tomography. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] R. Goldbohm,et al. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. , 2003, Carcinogenesis.
[28] D. Altieri,et al. Survivin in apoptosis control and cell cycle regulation in cancer. , 2003, Progress in cell cycle research.
[29] Nagara Tamaki,et al. Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[30] F. Blankenberg. To scan or not to scan, it is a question of timing: technetium-99m-annexin V radionuclide imaging assessment of treatment efficacy after one course of chemotherapy. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[31] Marcel Leist,et al. Four deaths and a funeral: from caspases to alternative mechanisms , 2001, Nature Reviews Molecular Cell Biology.
[32] F. Blankenberg,et al. Technetium-99m HYNIC-annexin V: a potential radiopharmaceutical for the in-vivo detection of apoptosis , 1999, European Journal of Nuclear Medicine.
[33] R. Davis,et al. Imaging of apoptosis (programmed cell death) with 99mTc annexin V. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] D. Altieri,et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. , 1998, Cancer research.
[35] K. Fujikawa,et al. Evaluation of annexin V as a platelet-directed thrombus targeting agent. , 1994, Thrombosis research.